Cerebral metabolic effects of acetyl-l-carnitine in rats during aging

Brain Research

Volumn 1259, Issue , 2009, Pages 32-39

  Freo, Ulderico ^a   Dam, Mauro ^b   Ori, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Ospedale/IRCCS   (Italy)

Author keywords

2 deoxyglucose; Acetylcarnitine; Acetylcholine; Aging; Brain metabolism; Rat

Indexed keywords

DEOXYGLUCOSE; LEVACECARNINE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN METABOLISM; BRAIN NERVE CELL; BRAIN REGION; CELL STRUCTURE; CONTROLLED STUDY; DRUG ACTIVITY; GLUCOSE METABOLISM; HIPPOCAMPUS; HYPOTHALAMUS; LIMBIC CORTEX; MALE; MOTOR CORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; VISUAL CORTEX;

ACETYLCARNITINE; AGING; ANIMALS; AUTORADIOGRAPHY; CARBON RADIOISOTOPES; CEREBRUM; DEOXYGLUCOSE; GLUCOSE; MALE; RATS; RATS, INBRED F344;

RATTUS;

EID: 61849135665     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.025     Document Type: Article

References (37)

1. Ames B.N., and Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann. N. Y. Acad. Sci. 1033 (2004) 108-116
2. Ando S., Tadenuma T., Tanaka Y., Fukui F., Kobayashi S., Ohashi Y., and Kawabata T. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J. Neurosci. Res. 66 (2001) 266-271
3. Antal A., Kovanecz I., and Bodis-Wollner I. Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey. Physiol. Behav. 56 (1994) 161-166
4. Bassant M.H., Jazat-Poindessous F., and Lamour Y. Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats. J. Cereb. Blood Flow Metab. 16 (1996) 1014-1025
5. Bertoni-Freddari C., Fattoretti P., Caselli U., and Paoloni R. Acetylcarnitine modulation of the morphology of rat hippocampal synapses. Anal. Quant. Cytol. Histol. 18 (1996) 275-278
6. Blokland A., Raaijmakers W., van der Staay F.J., and Jolles J. Differential effect of acetyl-l-carnitine on open field behavior in young and old rats. Physiol. Behav. 47 (1990) 783-785
7. Calabrese V., Scapagnini G., Latteri S., Colombrita C., Ravagna A., Catalano C., Pennisi G., Calvani M., and Butterfield D.A. Long-term ethanol administration enhances age-dependent modulation of redox state in different brain regions in the rat: protection by acetyl carnitine. Int. J. Tissue React. 24 (2002) 97-104
8. Caprioli A., Markowska A.L., and Olton D.S. Acetyl-L-carnitine: chronic treatment improves spatial acquisition in a new environment in aged rats. J. Gerontol. A. Biol. Sci. Med. Sci. 50 (1995) B232-236
9. Castorina M., Ambrosini A.M., Pacifici L., Ramacci M.T., and Angelucci L. Age-dependent loss of NMDA receptors in hippocampus, striatum, and frontal cortex of the rat: prevention by acetyl-L-carnitine. Neurochem. Res. 19 (1994) 795-798
10. Davis S., Markowska A.L., Wenk G.L., and Barnes C.A. Acetyl-L-carnitine: behavioral, electrophysiological, and neurochemical effects. Neurobiol. Aging 14 (1993) 107-115
11. Fiore L., and Rampello L. L-acetylcarnitine attenuates the age-dependent decrease of NMDA-sensitive glutamate receptors in rat hippocampus. Acta Neurol. 11 (1989) 346-350
12. Forloni G., Angeretti N., and Smiroldo S. Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J. Neurosci. Res. 37 (1994) 92-96
13. Freo U. Cerebral metabolic effects of serotonin drugs and neurotoxins. Life Sci. 59 (1996) 877-891
14. Freo U., Pizzolato G., Dam M., Ori C., and Battistin L. A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. J. Neural Transm. 109 (2002) 857-870
15. Ghirardi O., Caprioli A., Ramacci M.T., and Angelucci L. Effect of long-term acetyl-l-carnitine on stress-induced analgesia in the aging rat. Exp. Gerontol. 29 (1994) 274-569
16. Hagen T.M., Liu J., Lykkesfeldt J., Wehr C.M., Ingersoll R.T., Vinarsky V., Bartholomew J.C., and Ames B.N. Feeding acetyl-l-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. U S A. 99 (2002) 1870-1875
17. Hitzeman N. Cholinesterase inhibitors for Alzheimer's disease. Am. Fam. Physician. 74 (2006) 747-749
18. Hudson S., and Tabet N. Acetyl-l-carnitine for dementia. Cochrane Database Syst. Rev. 2 (2003) CD003158
19. Janiri L., Falcone M., Persico A., and Tempesta E. Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J. Neural. Transm. Gen. Sect. 86 (1991) 135-146
20. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2356-2361
21. Mancuso C., Bates T.E., Butterfield D.A., Calafato S., Cornelius C., De Lorenzo A., Dinkova Kostova A.T., and Calabrese V. Natural antioxidants in Alzheimer's disease. Expert. Opin. Investig. Drugs 16 (2007) 1921-1931
22. McCulloch J., and Iversen L.L. Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo. Neurochem Res. 16 (1991) 951-963
23. Montgomery S.A., Thal L.J., and Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-l-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int. Clin. Psychopharmacol. 18 (2003) 61-71
24. Onofrj M., Ghilardi M.F., Faricelli A., Bodis-Wollner I., and Calvani M. Effect of levo-acetylcarnitine on P300-like potentials of the normal monkey. Drugs Exp. Clin. Res. 13 (1987) 407-415
25. Ori C., Freo U., Pizzolato G., and Dam M. Effects of acetyl-l-carnitine on regional cerebral glucose metabolism in awake rats. Brain Res. 951 (2002) 330-335
26. Orzi F., Morelli M., Fieschi C., and Pontieri F.E. Metabolic mapping of the pharmacological and toxicological effects of dopaminergic drugs in experimental animals. Cerebrovasc. Brain Metab. Rev. 5 (1993) 95-121
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1980), Academic Press, New York
28. Pettegrew J.W., Klunk W.E., Panchalingam K., Kanfer J.N., and McClure R.J. Clinical and neurochemical effects of acetyl-l-carnitine in Alzheimer's disease. Neurobiol. Aging. 16 (1995) 1-4
29. Piovesan P., Quattrini G., Pacifici L., Taglialatela G., and Angelucci L. Acetyl-l-carnitine restores choline acetyltransferase activity in the hippocampus of rats with partial unilateral fimbria-fornix transection. Int. J. Dev. Neurosci. 13 (1995) 13-19
30. Sokoloff L. The radioactive deoxyglucose method-theory, procedure and applications for the measurements of local glucose utilization in the central nervous system. Adv. Neurochem. 4 (1982) 1-82
31. Soncrant T.T. Age-associated functional impairments of specific neurotransmitter systems: detection by pharmacological brain metabolism studies and criteria for design of human investigations. Int. J. Clin. Pharmacol. Res. 10 (1990) 27-47
32. Tafti M., Petit B., Chollet D., Neidhart E., de Bilbao F., Kiss J.Z., Wood P.A., and Franken P. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat. Genet. 34 (2003) 320-325
33. Tanaka Y., Sasaki R., Fukui F., Waki H., Kawabata T., Okazaki M., Hasegawa K., and Ando S. Acetyl-l-carnitine supplementation restores decreased tissue carnitine levels and impaired lipid metabolism in aged rats. J. Lipid Res. 45 (2004) 729-735
34. Terry Jr. A.V., and Buccafusco J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306 (2003) 821-827
35. Terwel D., Prickaerts J., Meng F., and Jolles J. Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur. J. Pharmacol. 287 (1995) 65-71
36. Tolu P., Masi F., Leggio B., Scheggi S., Tagliamonte A., De Montis M.G., and Gambarana C. Effects of long-term acetyl-l-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology 27 (2002) 410-420
37. Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., Chen J., Conway S.J., and Ganapathy V. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290 (1999) 1482-1492